Functional capabilities of marmoset T and B lymphocytes in primary in vitro antibody formation.

[1]  D. Nickerson,et al.  Marmoset species variation in the humoral antibody response: in vivo and in vitro studies. , 1978, Immunology.

[2]  D. Nickerson,et al.  Primary in vitro antibody formation by blood leucocytes of a subhuman primate. , 1976, Cellular immunology.

[3]  W. Paul,et al.  In vitro responses of CBA/N mice: spleen cells of mice with an X-linked defect that precludes immune responses to several thymus-independent antigens can respond to TNP-lipopolysaccharide. , 1976, Journal of immunology.

[4]  H. Mcdevitt,et al.  Antibody response of C3H in equilibrium (CKB X CWB)F1 tetraparental mice to poly-L(Tyr,Glu)-poly-D,L-Ala-poly-L-Lys immunization , 1976, The Journal of experimental medicine.

[5]  N. Shinohara,et al.  Differentiation of lymphoid cells: B cell as a direct target and T cell as a regulator in lipopolysaccharide-enhanced induction of immunoglobulin production. , 1976, Journal of immunology.

[6]  N. Gengozian,et al.  Characterization of the antibody response of the marmoset to sheep red blood cells. , 1976, Clinical and Experimental Immunology.

[7]  N. Gengozian,et al.  T and B lymphocytes in the marmoset: a natural haemopoietic chimera. , 1976, Clinical and experimental immunology.

[8]  P. Galanaud,et al.  Two processes for B-cell triggering by T-independent antigens as evidenced by the effect of azathioprine. , 1976, Cellular immunology.

[9]  J. Farrar.  The xenogeneic effect. I. Antigen and mitogen-stimulated human lymphocytes produce a non-antigen-specific factor which reconstitutes the antibody response of T cell-deficient mouse spleen cells. , 1975, Journal of immunology.

[10]  W. Paul,et al.  X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect , 1975, The Journal of experimental medicine.

[11]  N. Gengozian,et al.  Single‐Born Marmosets without Hemopoietic Chimerism: Naturally Occurring and Induced 1 , 1975, Journal of medical primatology.

[12]  D. Morrison,et al.  Immunologic properties of bacterial lipopolysaccharide (LPS). III. Genetic linkage between the in vitro mitogenic and in vivo adjuvant properties of LPS , 1976, The Journal of experimental medicine.

[13]  H. Oettgen,et al.  Suppression and enhancement of the T cell-dependent production of antibody to SRBC in vitro by bacterial lipopolysaccharide. , 1975, Journal of immunology.

[14]  D. Morrison,et al.  Stimulation of a T-independent primary anti-hapten response in vitro by TNP-lipopolysaccharide (TNP-LPS). , 1975, Journal of immunology.

[15]  N. Gengozian,et al.  Variation in T and B cell deficiency in different mouse allogeneic radiation chimeras. , 1974, Journal of immunology.

[16]  D. Katz,et al.  ACTIVATION OF T AND B LYMPHOCYTES IN VITRO , 1974, The Journal of experimental medicine.

[17]  D. Katz,et al.  ACTIVATION OF T AND B LYMPHOCYTES IN VITRO , 1974, The Journal of experimental medicine.

[18]  P. Felsburg,et al.  Immunological competence in non-human primates: differences observed in four species. , 1974, Clinical and experimental immunology.

[19]  A. Coutinho,et al.  MECHANISM OF THYMUS-INDEPENDENT IMMUNOCYTE TRIGGERING , 1974, The Journal of experimental medicine.

[20]  M. Greaves,et al.  Purification of human T and B lymphocytes. , 1974, Journal of immunology.

[21]  C. Warner,et al.  The immune response of tetraparental mice to two synthetic amino acid polymers: "high-conjugation" 2,4 dinitrophenyl-glutamic acid57-lysine38-alanine5 (DNP-GLA5) and glutamic acid60 alanine30 tyrosine10 (GAT10). , 1973, Journal of immunology.

[22]  K. Komuro,et al.  DIFFERENTIATION OF T CELLS INDUCED BY PREPARATIONS FROM THYMUS AND BY NONTHYMIC AGENTS , 1973, The Journal of experimental medicine.

[23]  R. Porter,et al.  IMMUNOLOGICAL RESPONSIVENESS AND TOLERANCE OF MARMOSET LYMPHOID TISSUE IN VITRO , 1973, Transplantation.

[24]  B. Marczynska,et al.  Induction of Neoplasms by Viruses in Marmoset Monkeys 1 , 1972, Journal of medical primatology.

[25]  L. Leserman,et al.  The third cell type required for the immune response of spleen cells in vitro. , 1971, Journal of immunology.

[26]  R. Porter,et al.  IMMUNOLOGICAL TOLERANCE AND REJECTION OF SKIN ALLOGRAFTS IN THE MARMOSET , 1969, Transplantation.

[27]  N. Gengozian.  MARMOSETS: THEIR POTENTIAL IN EXPERIMENTAL MEDICINE * , 1969, Annals of the New York Academy of Sciences.

[28]  P. Plotz,et al.  Assignment of direct and facilitated hemolytic plaques in mice to specific immunoglobulin classes. , 1968, Journal of immunology.

[29]  R. Dutton,et al.  IMMUNIZATION OF DISSOCIATED SPLEEN CELL CULTURES FROM NORMAL MICE , 1967, The Journal of experimental medicine.

[30]  K. Benirschke,et al.  Marrow Chimerism in Marmosets , 1962, Science.

[31]  G. B. Wislocki.  Observations on twinning in marmosets , 1939 .

[32]  F. Deinhardt,et al.  Hepatitis in primates. , 1976, Advances in virus research.

[33]  P. Baker,et al.  Regulation of the antibody response to type 3 pneumococcal polysaccharide. II. Mode of action of thymic-derived suppressor cells. , 1974, Journal of immunology.

[34]  N. Gengozian,et al.  HEMATOLOGIC AND CYTOGENETIC EVIDENCE FOR HEMATOPOIETIC CHIMERISM IN THE MARMOSET, TAMARINUS NIGRICOLLIS. , 1964, Cytogenetics.

[35]  James Peter Hill.  Croonian Lecture: The Developmental History of the Primates , 1932 .